Prosecution Insights
Last updated: October 10, 2026

Northwestern University

Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering

115 pending office actions • 62 art units • 106 examiners • 0 of 115 (0%) have an AI response strategy ready • 110 patents granted in the last 365 days

Analysis

Northwestern University has 116 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are spread across 63 distinct art units, reflecting a broad range of biological and pharmaceutical research. The university is working with 107 distinct examiners to advance these applications, which suggests that almost every pending matter is being reviewed by a unique individual. This broad distribution across 63 distinct art units requires a versatile legal strategy to address the specific requirements of many different technical groups.

Moussa Maher Haddad is the busiest examiner for the portfolio, managing 3 pending office actions. The remaining pending actions are distributed among the other 107 distinct examiners, showing a high degree of decentralization. This structure minimizes the risk of a single examiner creating a bottleneck for the entire portfolio. However, managing 116 pending office actions across 107 distinct examiners requires careful oversight to maintain consistency in arguments across the 63 distinct art units. The involvement of 63 distinct art units further highlights the complexity of the university's research portfolio, as it spans many different specialized areas of biotechnology examination.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

115
Total Pending OAs
76
Non-Final OAs
39
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 34 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

18
Overdue
1
Due this week
8
Due this month
2
Due in next 60 days
5
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 34 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (18)Due ≤ 7 days (1)Due ≤ 30 days (8)Due ≤ 60 days (2)Due later (5)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

76
Hard (66%)
34
Medium (30%)
5
Easy (4%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only1 (1%)
§101 + other23 (20%)
§103 only21 (18%)
§102 only5 (4%)
§112 only3 (3%)
Double-patenting only2 (2%)
Double-patenting + other8 (7%)
Multi-statute (no §101)52 (45%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

63
Life Sciences
55% of docket
2
Information Tech
2% of docket
1
Communications
1% of docket
3
Semiconductors
3% of docket
26
Mechanical / Eng
23% of docket
20
Business / Other
17% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

1,150 h
Manual time on pending OAs
230 h
Time saved (low, 20%)
402 h
Time saved (mid, 35%)
10.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HADDAD, MOUSSA MAHER 3 26.7% +33.0%
EBBINGHAUS, BRIANA NOEL 2 59.2% +62.7%
ZHU, JIANJIAN 2 58.8% +82.4%
SKROBARCZYK III, ROBERT ANTHONY 2 16.7% +16.3%
SALMON, KATHERINE D 2 42.8% +37.9%
EIX, EMILY FAY 2 45.5% +78.3%
SHIN, DANA H 2 26.9% +27.1%
BUTTICE, AUDREY L 2 47.6% +26.4%
BRUTUS, JOEL F 1 72.8% +17.8%
ALLEN, MARIANNE P 1 60.0% +18.3%

Hard Cases (79)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18780061 MACHINE LEARNING-BASED RISK-CLASSIFICATION OF ENDOMERIAL CANCER PATEL, SHERYL GOPAL 139d overdue
18245324 CLASSIFICATION OF FUNCTIONAL LUMEN IMAGING PROBE DATA HOEKSTRA, JEFFREY GERBEN 70d overdue
18572345 MULTIPLEXED ANTIGEN-BASED DETECTION OF SARS-COV-2 AND OTHER DISEASES USING NANOMECHANICAL SENSORS MCCORMACK, ERIN KATHLEEN 67d overdue
17421677 RAPID REVERSE TRANSCRIPTION QUANTITATIVE POLYMERASE CHAIN REACTION GIAMMONA, FRANCESCA FILIPPA 30d overdue
18009384 HYDRATION SENSOR FOR MONITORING AND DIAGNOSIS OF SKIN DISEASES IN ANY ENVIRONMENT AND APPLICATION OF SAME PARK, EVELYN GRACE 26d overdue
19122087 Systems and Methods to Identify Commercialization and Partnership Potential for Research Institutions SCHNEIDER, JOSHUA D 18d overdue
18865562 Anatomic Imaging Derived 4D Hemodynamics Using Deep Learning JASANI, ASHISH SHIRISH 16d overdue
18215701 Methods and Materials for Matching Chemistry of Individuals and Human Melanin JARRETT, LORE RAMILLANO 16d overdue

Interview Candidates (19)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18249057 USE OF REELIN FOR TREATING CARDIAC DISEASES BUTTICE, AUDREY L 16d overdue
17287668 APPARATUS AND METHOD FOR MEASURING PHYSIOLOGICAL PARAMETERS OF MAMMAL SUBJECT AND APPLICATIONS OF SAME HADDAD, MOUSSA MAHER 12d
19259540 SLIDING BIOACTIVE PEPTIDES FOR THERAPEUTIC DELIVERY ALLEN, MARIANNE P 14d
16951638 METHOD OF USING CHECKPOINT KINASE INHIBITOR THERAPY TO MODULATE ANTI-TUMORAL RESPONSE AGAINST CANCER AND SENSITIZE GLIOMAS TO IMMUNOTHERAPY BUTTICE, AUDREY L 57d
19311921 METHOD AND SYSTEM FOR HIGHLY PARALLEL ULTRASONIC DETECTION USING MICRO-RING RESONATOR IN AN ARRAY FORMAT BRUTUS, JOEL F —
19259714 HUMAN SPINAL CORD INJURY ORGANOIDS EBBINGHAUS, BRIANA NOEL —
18941862 BIOACTIVE AND ANTIOXIDANT SUPRAMOLECULAR POLYMER HYDROGELS FOR NEURAL CELL CULTURE ZHU, JIANJIAN —
18929526 COST EFFECTIVE CULTURE MEDIA AND PROTOCOL FOR HUMAN INDUCED PLURIPOTENT STEM CELLS ZHU, JIANJIAN —

Top Art Units

Art UnitApps
1652 4
3796 4
3791 4
1635 4
3797 3
1647 3
1626 3
3783 3
1682 3
1681 3

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19311921 METHOD AND SYSTEM FOR HIGHLY PARALLEL ULTRASONIC DETECTION USING MICRO-RING RESONATOR IN AN ARRAY FORMAT BRUTUS, JOEL F 3797 §102§103 Non-Final OA — Pending Aug 27, 2025
19259540 SLIDING BIOACTIVE PEPTIDES FOR THERAPEUTIC DELIVERY ALLEN, MARIANNE P 1647 §102§103§112Other Final Rejection 14d Pending Jul 03, 2025
19259714 HUMAN SPINAL CORD INJURY ORGANOIDS EBBINGHAUS, BRIANA NOEL 1632 §101§102§103§112DP Non-Final OA — Pending Jul 03, 2025
19227080 PROGRAMMABLE STREAMING ARCHITECTURE FOR LOW-ENERGY HUMAN-CENTRIC VISION APPLICATIONS NGUYEN, KATHLEEN V 2486 §103§112 Non-Final OA — Pending Jun 03, 2025
19215178 INFRARED THERMOGRAPHY FOR INTRAOPERATIVE FUNCTIONAL MAPPING POPESCU, GABRIEL VICTOR 3797 §101§102§103 Non-Final OA — Pending May 21, 2025
19129428 Fluid-Structure Instability-Based Physiomarker LY, TOMMY TAI 3797 §101 Non-Final OA — Pending May 13, 2025
19122087 Systems and Methods to Identify Commercialization and Partnership Potential for Research Institutions SCHNEIDER, JOSHUA D 3626 §101§103§112 Final Rejection 18d overdue Pending Apr 17, 2025
19111123 TRANSVENUS REVERSIBLE ELECTROPORATION WEBSTER, KARMEL JOHANNA — §102§103§112 Non-Final OA — Pending Mar 12, 2025
19053742 Efficient Ray-Tracing Rendering Processor with Optimization for Mobile Devices and Support of Inverse Rendering PATEL, SHIVANG I — §102§112 Non-Final OA — Pending Feb 14, 2025
19049835 OPERATIVE VAGINAL SCOPE MATTHEWS, TESSA M 3773 §102§103 Final Rejection 27d Pending Feb 10, 2025
18880219 REACTIVE OXYGEN SPECIES RESPONSIVE CLEAVABLE HIERARCHIAL METALLIC SUPRANANOSTRUCTURES SCHLEIS, DANIEL J 1784 §102§112 Non-Final OA — Pending Dec 30, 2024
18876553 METHODS OF FORMING STABLE CONDUCTIVE SURFACES CHEN, BRET P 1718 §103§112 Non-Final OA 20d Pending Dec 18, 2024
18865772 ELECTROTHERAPY SYSTEM AND APPLICATIONS OF SAME LUKJAN, SEBASTIAN X 3792 §102§103§112 Non-Final OA — Pending Nov 14, 2024
18865562 Anatomic Imaging Derived 4D Hemodynamics Using Deep Learning JASANI, ASHISH SHIRISH 3798 §102§103 Final Rejection 16d overdue Pending Nov 13, 2024
18941862 BIOACTIVE AND ANTIOXIDANT SUPRAMOLECULAR POLYMER HYDROGELS FOR NEURAL CELL CULTURE ZHU, JIANJIAN 1631 §103 Non-Final OA — Pending Nov 08, 2024
18929268 METHODS AND SYSTEMS RELATING TO ARTIFICIAL INTELLIGENCE FOR EARLY RECOGNITION OF RARE SKIN DISEASES BOYAR, NOAH WILLIAM — §101§103§112 Non-Final OA — Pending Oct 28, 2024
18929526 COST EFFECTIVE CULTURE MEDIA AND PROTOCOL FOR HUMAN INDUCED PLURIPOTENT STEM CELLS ZHU, JIANJIAN — §102§103§112DP Non-Final OA — Pending Oct 28, 2024
18914929 KERNEL-BASED ERGODIC SEARCH KARWAN, SIHAR A 3658 §103 Final Rejection 84d Pending Oct 14, 2024
18901448 METHOD AND SYSTEM FOR FUNCTIONAL AND STRUCTURAL REMODELING PROGRESSION IN ATRIAL FIBRILLATION SKROBARCZYK III, ROBERT ANTHONY — §101§103§112 Non-Final OA — Pending Sep 30, 2024
18886300 PLATFORM OF COMPOSABLE MAMMALIAN ELEMENTS OF TRANSCRIPTION (COMET) FRONDA, CHRISTIAN L 1652 §103§112Other Non-Final OA — Pending Sep 16, 2024
18842004 (3S,4R)-3-AMINO-4-(DIFLUOROMETHYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID AND RELATED COMPOUNDS AS SELECTIVE INACTIVATORS OF ORNITHINE AMINOTRANSFERASE RAMACHANDRAN, UMAMAHESWARI — §102§103DP Non-Final OA — Pending Aug 27, 2024
18792715 Synthesis of MEK7 Inhibitors and methods of Use Thereof OH, TAYLOR V — §102§112 Non-Final OA — Pending Aug 02, 2024
18780061 MACHINE LEARNING-BASED RISK-CLASSIFICATION OF ENDOMERIAL CANCER PATEL, SHERYL GOPAL 3685 §101§103 Final Rejection 139d overdue Pending Jul 22, 2024
18779742 METHOD AND SYSTEM TO PREDICT RADIOFREQUENCY HEATING OF MEDICAL IMPLANTS SILVA-AVINA, EMMANUEL 2673 §101§103 Non-Final OA — Pending Jul 22, 2024
18777366 Annuloplasty Ring For Receiving A Replacement Valve MATHEW, SEEMA — §103Other Non-Final OA — Pending Jul 18, 2024
18775012 ENGINEERED PROBIOTICS FOR DETECTION OF GASTROINTESTINAL DISEASE IN HUMANS DAVIS, RUTH A — §102Other Non-Final OA — Pending Jul 17, 2024
18776064 Methods for Sensitizing Gliomas to Immunotherapy KIFLE, BRUCK — §112 Non-Final OA — Pending Jul 17, 2024
18773685 METHOD TO EVALUATE AND FACT-CHECK AN AI LARGE LANGUAGE MODEL CHAT RESPONSE USING DOMAIN- SPECIFIC AND DOMAIN-AGNOSTIC GUIDANCE FOR PERSONALIZED MEDICAL PROVIDER-PATIENT CONSULT SAINT CYR, LEONARD — §103 Non-Final OA — Pending Jul 16, 2024
18737515 Systems and Methods for Latent Variable Modeling of Multiscale Neural Signals for Brain-Computer Interfaces PHAKOUSONH, DARAVANH — §101§102§112 Non-Final OA — Pending Jun 07, 2024
18737061 TISSUE EXPANDER WITH DRUG DELIVERY CAPABILITY THOMAS, NATALIE NICOLE — §102§103 Non-Final OA — Pending Jun 07, 2024
18735858 HUMAN SPINAL CORD INJURY ORGANOIDS EBBINGHAUS, BRIANA NOEL 1632 §102§103§112 Non-Final OA — Pending Jun 06, 2024
18735506 FORMULATIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF TUMOR METASTASIS AND TUMORIGENESIS SHIM, DAVID M. 1626 §103Other Non-Final OA — Pending Jun 06, 2024
18648764 ELECTRICAL MODULATION FOR THE TREATMENT OF BRAIN TUMORS HADDAD, MOUSSA MAHER 3796 §102§103§112 Non-Final OA — Pending Apr 29, 2024
18640956 CONDUCTIVE ELASTOMER FOR BLADDER REGENERATION WEBB, WALTER E 1612 §102§103 Non-Final OA — Pending Apr 19, 2024
18631727 STRUCTURALLY MODIFIED NANOSHEETS OF METAL OXIDES AND RELATED METHODS OSTWALT, ALEXIS ROSE 1788 §102§103§112 Non-Final OA — Pending Apr 10, 2024
18613535 CONDUCTIVE NANOMATERIALS AND COMPOSITES THEREOF NGUYEN, HAIDUNG D 1761 §102§112 Non-Final OA — Pending Mar 22, 2024
18691863 LIPIODOL FORMULATION FOR TRANSARTERIAL CHEMOIMMUNOEMBOLIZATION ARMSTRONG, SUSANNAH SIPPLE 1616 §102§103§112 Final Rejection — Pending Mar 13, 2024
18597748 SYSTEM AND METHOD FOR DETECTING AN EMOTIONAL STATE ABOUELELA, MAY A 3791 §102§103§112 Non-Final OA — Pending Mar 06, 2024
18595057 DIAGNOSIS OF ACUTE AND CHRONIC LUNG DISEASES BY QUANTIFYING SPINK1 LEVEL SALMON, KATHERINE D — §102§103§112Other Non-Final OA — Pending Mar 04, 2024
18583685 CATALASE MIMETIC PEPTIDES SHELTON, SYNPHANE LA'SHAWN 1652 §102§103§112 Final Rejection — Pending Feb 21, 2024
18420277 HIGH-EFFICIENCY GOLD RECOVERY BY ADDITIVE-INDUCED SUPRAMOLECULAR POLYMERIZATION OF CYCLODEXTRIN CRAIGO, BAHAR ALAWI 1734 §112 Non-Final OA — Pending Jan 23, 2024
18418897 LIPOTEICHOIC ACID FROM STAPHYLOCOCCUS EPIDERMIDIS AND ITS USE TO MODULATE NEURONAL ACTIVITY VIA PD-1 INHIBITORY SIGNALLING IN NEURONS OGUNBIYI, OLUWATOSIN A 1645 §102§112 Non-Final OA — Pending Jan 22, 2024
18412362 METHODS AND COMPOSITIONS FOR TREATMENT OF HEART FAILURE WITH PRESERVED EJECTION FRACTION DEKARSKE, MADELINE MCGUIRE 1622 §102§103 Non-Final OA — Pending Jan 12, 2024
18404041 DEVICES AND METHODS FOR LIGHT DELIVERY SKROBARCZYK III, ROBERT ANTHONY 3783 §102§103§112Other Non-Final OA — Pending Jan 04, 2024
18400950 METHOD OF ELECTRODEPOSITION IN SEAWATER FOR THE GROWTH OF CONSTRUCTION MATERIALS CONTRERAS, CIEL P — §103§112 Non-Final OA — Pending Dec 29, 2023
18572345 MULTIPLEXED ANTIGEN-BASED DETECTION OF SARS-COV-2 AND OTHER DISEASES USING NANOMECHANICAL SENSORS MCCORMACK, ERIN KATHLEEN 3791 §102§103§112 Final Rejection 67d overdue Pending Dec 20, 2023
18572447 INDOCARBOCYANINE LIPID DERIVATIVES FOR IN VIVO CARGO DELIVERY MCANANY, JOHN D 1625 §102§103§112 Final Rejection — Pending Dec 20, 2023
18544247 GENE THERAPY TREATMENT OF ATRIAL FIBRILLATION LANDSMAN, ROBERT S — §103DP Non-Final OA — Pending Dec 18, 2023
18531821 METHODS FOR SINGLE CELL NANOPORE SEQUENCING TECHNOLOGY AND DATA ANALYSIS SMITH, JENNIFER JOY — §101§102§103 Non-Final OA — Pending Dec 07, 2023
18517238 HALIDE PEROVSKITE OPTICAL STORAGE AND MEMORY ARRAYS TOBERGTE, NICHOLAS J 2824 §103 Non-Final OA — Pending Nov 22, 2023

View all 115 →

Managing Northwestern University's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Northwestern University have?

Northwestern University has 115 pending office actions as of October 2026, spread across 62 art units and 106 examiners.

Which USPTO examiner handles the most Northwestern University applications?

Moussa Maher Haddad has the most, with 3 of Northwestern University's pending office actions.

What technology area are Northwestern University's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month